Tell the FDA: +/-20% BG meter accuracy is not enough!
Update to post below: Amy Tenderich (Diabetes Mine) has posted a couple updates on this issue, including a white paper released by Roche and an interview with Ellen Ullman, mother to a son with type 1 and the only patient advocate at the FDA’s meeting. The interview is eye-opening around the lack of standards for BG meters, lack of information for consumers, and the industry’s general attitude that the status quo is good enough.
A number of blogs picked up this issue this week – passing it on to spread the word:
On March 16-17, the FDA held a meeting to review whether BG meter accuracy standards should be tightened. Some industry representatives argued against greater accuracy, suggesting that current standards are sufficient. (Sure – we can reduce a1cs without greater accuracy from the meters our management is based on, no problem!)
The FDA is taking comments on this issue until Tuesday, April 20, 2010 by 5:00 PM EST (according to the Federal Register).
To comment: click on the FDA Comments Docket (or go to www.regulations.gov and search for Docket No. FDA-2009-N-0604).
Flood the FDA with comments – let them know that industry can and needs to do better!